DENMARK - SEED Capital invests in Valderm

SEED Capital Denmark and other private investors have invested in Valderm, a Danish pharmaceutical company which specialises in developing psoriasis treatment. The company's product is still in its pre-clinical trial stage, but is expected to be on the market in a few years.